Rohan Jeyarajah, MD, hepatopancreaticobiliary surgeon, Methodist Richardson Medical Center, discusses aggressive treatment while preserving quality of life in patients with colorectal cancer (CRC).

The use of SIR-Spheres® Y-90 resin microspheres earlier during a patient’s disease could allow for more lines of chemotherapy due to prolonged survival, Jeyarajah says. Sequencing Y-90 before the liver is overburdened can benefit patients with CRC, Jeyarajah adds. Surgical resection remains an aim for treating patients with CRC, and Y-90 could help achieve that goal, Jeyarajah explains.

While finding ways to implement to best treatment options is important, oncologists must preserve the quality of life for patients by delivering agents over a longer period, Jeyarajah continues. With the correct sequencing of therapy, that can be achieved to help patients live longer, Jeyarajah concludes.

Videos

Rohan Jeyarajah, MD, discusses aggressive treatment while preserving quality of life in patients with colorectal cancer.


Dr. Jeyarajah on Aggressive Treatment while Preserving Quality of Life in CRC

Rohan Jeyarajah, MD, hepatopancreaticobiliary surgeon, Methodist Richardson Medical Center, discusses the potential role of SIR-Spheres

 Y-90 resin microspheres from Sirtex Medical in colorectal cancer (CRC) with liver metastases.

Although the data with maintenance therapy in CRC with liver metastases are inconclusive, the general goal of maintenance treatment is to de-escalate chemotherapy, Jeyarajah explains. For example, a patient could receive full-dose FOLFOX chemotherapy for 12 cycles but de-escalate to 5-fluorouracil plus a biologic agent in the maintenance setting if they have small volume disease to optimize quality of life (QOL).

Y-90 resin may be utilized in patients with liver-predominant disease to further improve QOL and eliminate the need for chemotherapy completely in the maintenance setting, Jeyarajah says. However, if patients have other sites of disease like lung metastases or retroperitoneal lymphadenopathy, chemotherapy should be continued as maintenance.

Ultimately, Y-90 resin may have a role as maintenance therapy in patients with liver-predominant disease to control liver disease with minimal toxicity, Jeyarajah concludes.

Rohan Jeyarajah, MD, discusses the potential role of SIR-Spheres® Y-90 resin microspheres from Sirtex Medical in colorectal cancer with liver metastases.  

Rohan Jeyarajah, MD

Articles

Dr. Jeyarajah on Aggressive Treatment while Preserving Quality of Life in CRC

Dr. Jeyarajah on SIR-Spheres® Y-90 Resin Microspheres as Maintenance in CRC With Liver Metastases